The UK’s National Health Service (NHS) is one of the world’s most admired health systems, but it is frequently slow in adopting new drugs and technologies. The UK Government is launching a new scheme, which it believes can address this lag.
From April, five drugs or medical devices will be selected for a new fast-track process each year, ensuring their uptake on the NHS much sooner than would otherwise be possible. This accelerated pathway for new drugs and therapies could bring benefits for niche innovators, such as makers of digital health products.
